&nbsp;

Jan 2025

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Sep 2025

Drug

pomalidomide

Other Name(s): Pomalyst®

Quick Link(s):

Apr 2025

Drug

pembrolizumab

Other Name(s): Keytruda®

Quick Link(s):

Sep 2025

Regimen

PGLDX

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Funding:

New Drug Funding Program

Liposomal DOXOrubicin - Single Agent Treatment of Platinum Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer

New Drug Funding Program

Liposomal Doxorubicin - Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer

pegylated liposomal DOXOrubicin

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

PGLDX

Cancer Type:

Sarcoma,

Kaposi's Sarcoma

Intent: Palliative

Funding:

New Drug Funding Program

Liposomal Doxorubicin - HIV-positive Kaposi's Sarcoma

pegylated liposomal DOXOrubicin

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

PGLDX

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

pegylated liposomal DOXOrubicin (Compassionate)

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

PEMB

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and No Prior Ipilimumab

New Drug Funding Program

Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer (Second or Subsequent Line)

New Drug Funding Program

Pembrolizumab - Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB(FIXED)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Drugs Used:

pembrolizumab (Unfunded)